Infection rates in standard vs. hydrogel coated ventricular catheters

Canadian Journal of Neurological Sciences

Volumn 31, Issue 4, 2004, Pages 506-510

  Kaufmann, Anthony M ^a   Lye, Tara ^b   Redekop, Gary ^c   Brevner, Angela ^c   Hamilton, Mark ^d   Kozey, Michelle ^a   Easton, David ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN;

ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CATHETER; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYDROGEL; INFECTION; INFECTION RATE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MATERIAL COATING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 9744224311     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100003723     Document Type: Article

References (43)

1. Aucoin PJ, Kotilainen HR, Gantz NM, et al. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med 1986; 80(3):369-376.
2. Blomstedt GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg 1985; 62(5):694-697.
3. Chan KH, Mann KS. Prolonged therapeutic external ventricular drainage: a prospective study. Neurosurgery 1988; 23(4):436-438.
4. Chaparro MJ, Pritz MB, Yonemura KS. Broviac ventriculostomy for long-term external ventricular drainage. Pediatr Neurosurg 1991; 17(4):208-212.
5. Friedman WA, Vries JK. Percutaneous tunnel ventriculostomy. Summary of 100 procedures. J Neurosurg 1980; 53(5);662-665.
6. Gopinath SP, Robertson CS, Contant CF, et al. Clinical evaluation of a miniature strain-gauge transducer for monitoring intracranial pressure. Neurosurgery 1995; 36(6):1137-1140.
7. Kanter RK, Weiner LB, Patti AM, Robson LK. Infectious complications and duration of intracranial pressure monitoring. Crit Care Med 1985; 13(10):837-839.
8. Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310(9):553-559.
9. Narayan RK, Kishore PR, Becker DP, et al. Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury. J Neurosurg 1982; 56(5):650-659.
10. North B, Reilly P. Comparison among three methods of intracranial pressure recording. Neurosurgery 1986; 18(6):730-732.
11. Paramore CG, Turner DA. Relative risks of ventriculostomy infection and morbidity. Acta Neurochir (Wien) 1994; 127(1-2);79-84.
12. Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 1984; 41(1):26-29.
13. Rosner MJ, Becker DP. ICP monitoring: complications and associated factors. Clin Neurosurg 1976; 23:494-519.
14. Schultz M, Moore K, Foote AW. Bacterial ventriculitis and duration of ventriculostomy catheter insertion. J Neurosci Nurs 1993; 25(3):158-164.
15. Smith RW, Alksne JF. Infections complicating the use of external ventriculostomy. J Neurosurg 1976; 44(5):567-570.
16. Stenager E, Gerner-Smidt P, Kock-Jensen C. Ventriculostomy-related infections - an epidemiological study. Acta Neurochir (Wien) 1986; 83(1-2):20-23.
17. Sundbarg G, Nordstrom CH, Soderstrom S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 1988; 2(4):485-495.
18. Winfield JA, Rosenthal P, Kanter RK, Casella G. Duration of intracranial pressure monitoring does not predict daily risk of infectious complications. Neurosurgery 1993; 33(3):424-430.
19. Wyler AR, Kelly WA. Use of antibiotics with external ventriculostomies. J Neurosurg 1972; 37(2):185-187.
20. Yablon JS, Lantner HJ, McCormack TM, et al. Clinical experience with a fiberoptic intracranial pressure monitor. J Clin Monit 1993; 9(3):171-175.
21. Levin AB, Braun SR, Grossman JE. Physiological monitoring of the head-injured patient. Clin Neurosurg 1982; 29:240-287.
22. Clark WC, Muhlbauer MS, Lowrey R, et al. Complications of intracranial pressure monitoring in trauma patients. Neurosurgery 1989; 25(1):20-24.
23. Ohrstrom JK, Skou JK, Ejlertsen T, Kosteljanetz M. Infected ventriculostomy: bacteriology and treatment. Acta Neurochir (Wien) 1989; 100(1-2):67-69.
24. Cook AD, Sagers RD, Pitt WG. Bacterial adhesion to poly(HEMA)-based hydrogels. J Biomed Mater Res 1993; 27(1):119-126.
25. Pearce RS, West LR, Rodeheaver GT, Edlich RF. Evaluation of a new hydrogel coating for drainage tubes. Am J Surg 1984; 148(5):687-691.
26. Stenager E, Gerner-Smidt P, Kock-Jensen C. Ventriculostomy-related infections - an epidemiological study. Acta Neurochir (Wien) 1986; 83(1-2):20-23.
27. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20(5):271-274.
28. Donetz AP, Harvey RA, Greco RS. Stability of antibiotics bound to polytetrafluoroethylene with cationic surfactants. J Clin Microbiol 1984; 19(1):1-3.
29. Hamilton AJ, Orozco J, Narotam P, Bowersock T. Efficacy of vancomycin/tri-iododecyclemethyl ammonium chloride-coated ventriculostomy catheters in reducing infection. Neurosurgery 1997;40(5):1043-1049.
30. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265(18):2364-2368.
31. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985; 97(5):547-551.
32. Trooskin SZ, Donetz AP, Baxter J, Harvey RA, Greco RS. Infection-resistant continuous peritoneal dialysis catheters. Nephron 1987; 46(3):263-267.
33. Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984;310(9):553-559.
34. Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996; 85(3):419-424.
35. Kanter RK, Weiner LB, Patti AM, Robson LK. Infectious complications and duration of intracranial pressure monitoring. Crit Care Med 1985; 13(10):837-839.
36. Sundbarg G, Nordstrom CH, Soderstrom S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 1988; 2(4):485-495.
37. Alleyne CH Jr, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery 2000; 47(5):1124-1127.
38. Aucoin PJ, Kotilainen HR, Gantz NM, et al. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med 1986; 80(3):369-376.
39. Blomstedt GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg 1985; 62(5):694-697.
40. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003; 98(4):725-730.
41. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340(1):1-8.
42. Marik PE, Abraham G, Careau P, Varon J, Fromm RE Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27(6):1128-1131.
43. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127(4):267-274.